The global amlodipine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Amlodipine is a calcium channel blocker medication used to treat high blood pressure (hypertension), and coronary artery disease in people with either stable angina (where chest pain occurs mostly after physical or emotional stress) or vasospastic angina (where it occurs in cycles) and without heart failure. The major factor expected to drive the market is the increasing incidence of hypertension globally. Furthermore, it supports to lower blood pressure by relaxing the blood vessels that prevent heart attack, stroke, and kidney problems along with treating hypertension. The major causes of increasing hypertension is smoking, diabetes, obesity or being overweight, lack of physical activity, deficiency in vitamin D, stress, and high salt or alcohol intake levels.
Moreover, by September 2019, around 1.1 billion people globally have hypertension according to World Health Organization (WHO) data, most living in middle and low-income countries. This n turn, is driving the demand for amlodipine tablets. In addition, increasing investments in R&D activities in the pharmaceutical sector is further expected to propel the growth of the global amlodipine market during the forecast period. Additionally, it also supports for the treatment of several other diseases when given in the combination with a variety of medications such as atorvastatin to prevent CVD events and high cholesterol, aliskiren/hydrochlorothiazide to reduce blood pressure, with benazepril to block the conversion of angiotensin I to angiotensin II in the RAAS pathway, among others.
Some major players in the market include Alkem Laboratories Ltd., Dr Reddy’s Laboratories Ltd., and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Bristol Lab launched 2.5 mg amlodipine drug which is indicated for the treatment of patients with hypertension, chronic stable angina pectoris, and vasospastic (Prinzmetal) angina. The 2.5mg tablets can now be prescribed for paediatric population, children and adolescents with hypertension from 6 to 17 years of age, who need a 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after four weeks.
(Get 15% Discount on Buying this Report)
Get Sample Copy of amlodipine market at:
https://orionmarketreports.com/request-sample/?id=96616&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Top major key player:
Alkem Laboratories Ltd., Dr Reddy’s Laboratories Ltd., and Pfizer Inc., among others.
A full report of amlodipine market is available at:
https://orionmarketreports.com/global-amlodipine-market-2/96616/
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Amlodipine Market Report by Segment
By Type
2.5 mg Tablets
5 mg Tablets
10 mg Tablets
By Application
High Blood Pressure
Heart Disease
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
